
Paxlovid ‘inaccessible’ to many patients in Canada. Here’s why that needs to change
Global News
With COVID-19 infections surging across Canada, experts say the patchwork distribution system for Paxlovid throughout the country may inhibit those who most need the drug.
A pill to treat COVID-19 appears to be the country’s best hope, outside of vaccines and strong public health measures, to keep hospitals from being overrun with cases of the virus now and in the future, doctors say.
But with infections surging across the country, experts say the patchwork distribution system for Paxlovid in various parts of Canada may inhibit those who most need the drug from getting it in time.
Paxlovid, an antiviral, has shown a 90 per cent reduction in hospitalizations among unvaccinated patients with the Delta variant who received the drug within five days of symptom onset.
Those who might need the drug the most would do well to learn ahead of time how they might access it, the country’s chief public health officer said this week.
“My message to all Canadians who may be at high risk, such as the immunocompromised: figure out in your community, right now, how you can get access to that medication should you need it because it is a bit different across different areas of Canada,” Dr. Theresa Tam said on Tuesday.
The federal government has distributed about 150,000 courses of Paxlovid to the provinces and territories, Tam said. Most of the provinces have a centralized distribution system for the drug, often through hospitals and assessment centres, and eligibility varies across the country.
“I think all of us would like to see Paxlovid being mobilized more widely,” Tam said, adding that Health Canada is working with various jurisdictions on the issue.
“We will be using these kinds of medications in a more significant way as we have more access to antivirals in the future, which is great news. We just need to know how to get it out to people fast.”













